Dirk Lievens Selected Research

Tumor Necrosis Factor Receptor-Associated Peptides and Proteins

2/2014	Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance.
5/2008	The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Lievens Research Topics

Disease

16	Atherosclerosis 12/2017 - 05/2007
6	Inflammation (Inflammations) 01/2018 - 02/2010
4	Thrombosis (Thrombus) 01/2018 - 11/2010
4	Atherosclerotic Plaque (Atheroma) 01/2017 - 05/2007
2	Rupture 01/2018 - 05/2007
2	Muscle Cramp (Cramp) 04/2012 - 04/2012
1	Diarrhea 04/2022
1	Nausea 04/2022
1	Vomiting 04/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2022
1	Idiopathic Pulmonary Fibrosis 04/2022
1	Aneurysm (Aneurysms) 01/2018
1	Aortic Dissection 01/2018
1	Abdominal Aortic Aneurysm 01/2018
1	Obesity 02/2014
1	Hypercholesterolemia 03/2013
1	Hyperlipidemias (Hyperlipidemia) 05/2012
1	Vascular Diseases (Vascular Disease) 05/2012
1	Carotid Stenosis (Carotid Artery Stenosis) 04/2012
1	Autoimmune Diseases (Autoimmune Disease) 04/2012
1	Neoplasms (Cancer) 03/2010
1	Neoplasm Metastasis (Metastasis) 03/2010
1	Fibrosis (Cirrhosis) 02/2010
1	Vascular Remodeling 05/2008
1	Neointima 05/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2007

Drug/Important Bio-Agent (IBA)

10	Apolipoproteins E (ApoE)IBA 01/2018 - 02/2010
9	CD40 Ligand (CD40L)IBA 01/2018 - 05/2007
4	ApolipoproteinsIBA 01/2018 - 02/2010
3	TNF Receptor-Associated Factor 2 (TRAF2)IBA 02/2014 - 05/2008
2	Phosphotransferases (Kinase)IBA 06/2015 - 03/2010
2	CollagenIBA 06/2015 - 05/2008
2	Chemokine ReceptorsIBA 03/2014 - 05/2012
2	Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA 02/2014 - 05/2008
2	Proteins (Proteins, Gene)FDA Link 04/2012 - 04/2012
2	AntibodiesIBA 04/2012 - 09/2007
2	LigandsIBA 03/2010 - 05/2007
1	nintedanibIBA 04/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018
1	Angiotensin IIIBA 01/2018
1	Matrix Metalloproteinase 13IBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-3IBA 01/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	Thrombin FDA Link 03/2016
1	Inflammation MediatorsIBA 03/2016
1	LipidsIBA 10/2015
1	Glycoproteins (Glycoprotein)IBA 06/2015
1	IntegrinsIBA 06/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2015
1	Chemokine CCL5IBA 03/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2013
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 12/2013
1	CytokinesIBA 12/2013
1	Interleukin-8B ReceptorsIBA 03/2013
1	CX3C Chemokine Receptor 1IBA 05/2012
1	CathelicidinsIBA 04/2012
1	DNA (Deoxyribonucleic Acid)IBA 04/2012
1	Nucleic AcidsIBA 04/2012
1	InterferonsIBA 04/2012
1	Interferon Type IIBA 04/2012
1	anti-dsDNA autoantibodyIBA 04/2012
1	Antimicrobial PeptidesIBA 04/2012
1	Phenobarbital (Luminal)FDA Link 03/2012
1	oxidized low density lipoproteinIBA 11/2011
1	Caveolin 1IBA 11/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2011
1	Lipoproteins (Lipoprotein)IBA 06/2010
1	tyrosine receptor (receptor, tyrosine)IBA 03/2010
1	MitogensIBA 03/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2010
1	Therapeutic UsesIBA 02/2010
1	Peptide Hydrolases (Proteases)FDA Link 05/2008
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 05/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	AntigensIBA 09/2007

Therapy/Procedure

1	Drug Tapering 04/2022
1	Transplantation 03/2010